GOOD OR BAD NEWS for House, M.D.?

Human Genome Sciences Inc. said its experimental drug Benlysta met the goals of a late-stage study in treating lupus, a notoriously hard-to-treat autoimmune disease that hasn't seen a new therapy in decades.

At least in the first two seasons, when I used to watch it, he always started saying "It's lupus!"

UPDATE. It's never lupus!

But then one day...